These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Clinical considerations on a new estro-progestin combination: ethinylestradiol-medroxyprogesterone acetate]. Bailo U; Valsecchi A Minerva Ginecol; 1965 Sep; 17(17):890-3. PubMed ID: 5852444 [No Abstract] [Full Text] [Related]
3. A comprehensive review of injectable contraception with special emphasis on depot medroxyprogesterone acetate. Fraser IS; Weisberg E Med J Aust; 1981 Jan; 1(SP1):3-19. PubMed ID: 6453269 [No Abstract] [Full Text] [Related]
4. [Gestagens and the treatment of hot flushes in the postmenopausal period]. Presl J Cesk Gynekol; 1983 Feb; 48(1):47-9. PubMed ID: 6219756 [No Abstract] [Full Text] [Related]
5. [Improvement of climacteric syndrome with MPA treatment (author's transl)]. Terzi I; Zagami L; Zanno C Ann Osp Maria Vittoria Torino; 1980; 23(7-12):447-51. PubMed ID: 6459049 [No Abstract] [Full Text] [Related]
6. The effect of medroxyprogesterone acetate and ethinyl estradiol on varied problems associated with the menstrual cycle. A comparison of a combination to a sequential regimen. Miyamoto J Acta Obstet Gynaecol Jpn; 1970 Oct; 17(4):233-8. PubMed ID: 4249753 [No Abstract] [Full Text] [Related]
7. Perimenopausal patients: treatment with continual escalating-dose synthetic estrogen with added progestogen. Roland M; Stubbs S; Ober WB Geriatrics; 1972 May; 27(5):138-45. PubMed ID: 5022804 [No Abstract] [Full Text] [Related]
8. Anabolizing and anti-pain effect of the short-term treatment with medroxyprogesterone acetate (MAP) at high oral doses in oncology. Pannuti F; Burroni P; Fruet F; Piana E; Strocchi E; Di Marco AR; Cricca A; Camaggi CM Panminerva Med; 1980; 22(3):149-56. PubMed ID: 6451859 [No Abstract] [Full Text] [Related]
10. Phase II evaluation of oral medroxyprogesterone acetate in advanced breast cancer: a Northern California Oncology Group Study. Tan YO; Hendrickson C; McWhirter K; Kohler M; Hannigan JF; Carlson RW Cancer Treat Rep; 1987 Oct; 71(10):969-70. PubMed ID: 2958131 [No Abstract] [Full Text] [Related]
11. Effects of medroxyprogesterone acetate employed as a long-term injectable contraceptive. Ringrose CA J Reprod Med; 1972 Feb; 8(2):75-9. PubMed ID: 4666624 [No Abstract] [Full Text] [Related]